Related Experiment Video
Updated: Mar 7, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
The p53-binding protein 1-Tudor-interacting repair regulator complex participates in the DNA damage response
Aili Zhang1, Bo Peng1, Ping Huang1
1From the Department of Cancer Biology, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio 44195 and.
Abstract:
The 53BP1-dependent end-joining pathway plays a critical role in double strand break repair and is uniquely responsible for cellular sensitivity to poly(ADP-ribose) polymerase inhibitors (PARPi) in BRCA1-deficient cancers. We and others have investigated the downstream effectors of 53BP1, including replication timing regulatory factor 1 (RIF1) and Pax transactivation domain-interacting protein (PTIP), in the past few years to elucidate how loss of the 53BP1-dependent repair pathway results in PARPi resistance in BRCA1 patients. However, questions regarding the upstream regulation of the 53BP1 pathway remain unanswered. In this study, we identified the Tudor-interacting repair regulator (TIRR) that specifically associates with the ionizing radiation-induced foci formation region of 53BP1. 53BP1 and TIRR form a stable complex, which is required for their expression. Moreover, the 53BP1-TIRR complex dissociates after DNA damage, and this dissociation may be ataxia telangiectasia mutated-dependent. Similar to 53BP1, loss of TIRR restores PARPi resistance in BRCA1-deficient cells. Collectively, our data identified a novel 53BP1-TIRR complex in DNA damage response. TIRR may play both positive and negative roles in 53BP1 regulation. On the one hand, it stabilizes 53BP1 and thus positively regulates 53BP1. On the other hand, its association with 53BP1 prevents 53BP1 localization to sites of DNA damage, and thus TIRR is also an inhibitor of 53BP1.
Insights
Researchers discovered Tudor-interacting repair regulator (TIRR), a protein that forms a complex with 53BP1. This TIRR-53BP1 complex impacts DNA repair and poly(ADP-ribose) polymerase inhibitor (PARPi) resistance in BRCA1-deficient cancers.
Area of Science:
- DNA Damage Response
- Cancer Biology
- Molecular Oncology
Background:
- The 53BP1-dependent end-joining pathway is crucial for DNA double-strand break repair.
- This pathway dictates cellular sensitivity to poly(ADP-ribose) polymerase inhibitors (PARPi) in BRCA1-deficient cancers.
- Upstream regulators of the 53BP1 pathway remain largely unknown.
Purpose of the Study:
- To identify novel regulators of the 53BP1 DNA repair pathway.
- To elucidate the role of these regulators in BRCA1-deficient cancer cells and PARPi resistance.
Main Methods:
- Co-immunoprecipitation to identify interacting proteins.
- Western blotting to assess protein expression and complex formation.
- Cellular assays to evaluate DNA repair and PARPi sensitivity.
Main Results:
- Identification of Tudor-interacting repair regulator (TIRR) as a novel 53BP1-interacting protein.
- 53BP1 and TIRR form a stable complex essential for their expression.
- The 53BP1-TIRR complex dissociates upon DNA damage in an ATM-dependent manner.
- Loss of TIRR restores PARPi resistance in BRCA1-deficient cells, similar to 53BP1 loss.
Conclusions:
- A novel 53BP1-TIRR complex has been identified in the DNA damage response.
- TIRR plays a dual role in 53BP1 regulation: stabilizing 53BP1 and inhibiting its localization to DNA damage sites.
- TIRR is a potential therapeutic target for overcoming PARPi resistance in BRCA1-deficient cancers.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Abnormal Proliferation
Restarting Stalled Replication Forks
Homologous Recombination

